《大行報告》瑞銀微升中國鐵塔(00788.HK)目標價至2.27元 評級「買入」
瑞銀發表研究報告,指中國鐵塔(00788.HK)將於下周公布業績,預期其去年第四季業績穩固,收入按年升7.6%,主因來自鐵塔收入持續改善,但部份被跨行業站址應用與信息業務(TSSAI)因高基數而增長放緩所抵銷。預期EBITDA按年升7%,反映因持續投資新業務致利潤率微跌;純利料按年升19%,與此前季度相若。
該行指出,投資者關心中國鐵塔與營運商現有合約屆滿,以及對今年收入展望,但相信有關憂慮未能完全在去年業績中紓解;瑞銀預期,鐵塔未來12月個月經營持續改善,將可帶動股份估值重評,重申「買入」評級,目標價由2.26元微升至2.27元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.